Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Sex Based Pharmacological Treatment in Patients With Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program Publisher



Gharipour M1 ; Kelishadi R2 ; Toghianifar N2 ; Mackie M3 ; Yazdani M2 ; Noori F4 ; Sarrafzadegan N2
Authors

Source: African Journal of Pharmacy and Pharmacology Published:2011


Abstract

Pharmacological therapy is a critical step in the management of individuals with the metabolic syndrome (MetS) when lifestyle modifications cannot achieve the therapeutic goals. However, it has been well-documented that there is no single best therapy other than weight loss, and that treatment should be targeted at individual components of the MetS. The objective of this study was to investigate the treatment of individual components of the MetS in a population-based sample of individuals with clustering MetS components. In a cross-sectional population-based survey, we studied a randomly collected sample of men and women who had participated in the baseline survey of a community-based program in three Central Iranian counties in 2000 to 2001. Demographic data, medical status, and drug history were obtained by questionnaire. We evaluated the association between clustering of the MetS components and pharmacological treatment of cardiovascular risk factors. The most common pharmacologic agents prescribed for individuals with the MetS were beta-blockers (72.8%), followed by lipid-lowering agents (36%) with no significant gender difference. A high level of compliance with drug treatment was noted. Further research is warranted to understand the compliance behavior of patients with the MetS. © 2011 Academic Journals.
Other Related Docs
13. Metabolic Syndrome and Health-Related Quality of Life in Iranian Population, Journal of Research in Medical Sciences (2011)
15. Metabolic Syndrome in Iranian Elderly, ARYA Atherosclerosis (2012)